派博傳思國際中心

標(biāo)題: Titlebook: Intraperitoneal Cancer Therapy; C. William Helm,Robert P. Edwards (Vice Chairman o Book 2007 Humana Press 2007 cancer.carcinoma.clinical t [打印本頁]

作者: MASS    時(shí)間: 2025-3-21 19:07
書目名稱Intraperitoneal Cancer Therapy影響因子(影響力)




書目名稱Intraperitoneal Cancer Therapy影響因子(影響力)學(xué)科排名




書目名稱Intraperitoneal Cancer Therapy網(wǎng)絡(luò)公開度




書目名稱Intraperitoneal Cancer Therapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Intraperitoneal Cancer Therapy被引頻次




書目名稱Intraperitoneal Cancer Therapy被引頻次學(xué)科排名




書目名稱Intraperitoneal Cancer Therapy年度引用




書目名稱Intraperitoneal Cancer Therapy年度引用學(xué)科排名




書目名稱Intraperitoneal Cancer Therapy讀者反饋




書目名稱Intraperitoneal Cancer Therapy讀者反饋學(xué)科排名





作者: 輕率的你    時(shí)間: 2025-3-21 23:12

作者: disparage    時(shí)間: 2025-3-22 01:01
Maurie Markman MDmade here and there. I withstood, how- ever, the temptation to expand considerably the book by adding completely new subjects. Nevertheless, a few pages on recent developments needed to be inserted. Among them are, naturally, the discussion of ceramic (high-tempera- ture) superconductors, and certain elements978-3-662-02954-1
作者: 粗糙濫制    時(shí)間: 2025-3-22 07:48
Ralph S. Freedman MD, PhDidation-reduction potentials, and after a brief survey of organic superconductors, various applications of organic semiconductor devices are described. This book will be useful not only for researchers but also for graduate students as a valuable reference..978-4-431-56648-9978-4-431-55264-2
作者: 有罪    時(shí)間: 2025-3-22 08:45

作者: Diuretic    時(shí)間: 2025-3-22 14:10

作者: 粗糙    時(shí)間: 2025-3-22 19:35

作者: commensurate    時(shí)間: 2025-3-22 22:53
C. William Helm MA, MB BChir, FRCSield a variety of information about the doping process and the orientation of the inserted halogen (poly-)anions with respect to the (CH). chains. Stretch-oriented (CH). samples, which represent quasi-one dimensional systems, were used in all investigations. This allows us to exploit the linear pola
作者: galley    時(shí)間: 2025-3-23 03:35

作者: Sputum    時(shí)間: 2025-3-23 07:59

作者: CLOWN    時(shí)間: 2025-3-23 10:02
Bing Yi MD,Jason M. Foster MD,Brian W. Loggie MDctric conductivity in stretch-oriented samples and whether the transport mechanisms are one-, two-, or three-dimensional or might even have a "fractal dimension978-3-642-84707-3978-3-642-84705-9Series ISSN 0171-1873 Series E-ISSN 2197-4179
作者: 帶來    時(shí)間: 2025-3-23 14:46
Frans A. N. Zoetmulder MDctric conductivity in stretch-oriented samples and whether the transport mechanisms are one-, two-, or three-dimensional or might even have a "fractal dimension978-3-642-84707-3978-3-642-84705-9Series ISSN 0171-1873 Series E-ISSN 2197-4179
作者: enterprise    時(shí)間: 2025-3-23 19:09

作者: Aerate    時(shí)間: 2025-3-24 00:29
great part of the work presented was concerned with conjuga- ted systems. Additional presentations dealt with other systems such as bio- polymers, photopolymers978-3-642-82571-2978-3-642-82569-9Series ISSN 0171-1873 Series E-ISSN 2197-4179
作者: 無辜    時(shí)間: 2025-3-24 06:25
Immunobiology and Intraperitoneal Immunobiologics in Ovarian Cancer, strategies require pharmacodynamic and immunologic end points that can guide each phase in the development of an effective approach. Review of systemic and intraperitoneal (IP) immunotherapy trials of interferon (IFN) α, IFNγ, and interleukin 2 (IL2), as well as newer agents such as IL12 and Flt3 l
作者: chassis    時(shí)間: 2025-3-24 09:29

作者: 奇怪    時(shí)間: 2025-3-24 13:12

作者: Junction    時(shí)間: 2025-3-24 16:37

作者: temperate    時(shí)間: 2025-3-24 18:59
2364-1134 n treatment.The future direction of intraperitoneal chemothe.Intraperitoneal Cancer Therapy investigates intraperitoneal chemotherapy in a variety of complex and interesting ways. The volume details major clinical trails to date, including immunotherapy, hyperthermic treatment of colo-rectal and ova
作者: 使害羞    時(shí)間: 2025-3-25 02:51
Intraperitoneal Chemotherapy: Technique and Complications,lace the device and remove it unused at the bedside later, than to forego placement and have to reoperate to place the device at a second procedure. The second procedure to place an IP catheter is an important barrier to initiating IP chemotherapy, and also delays proper treatment.
作者: tympanometry    時(shí)間: 2025-3-25 05:48
Hyperthermia and Chemotherapy: The Science,reatments. Basic science is primed to exert a substantial role in extending our therapeutic options through the clarification of current therapeutic mechanisms, as well as the generation of novel treatments.
作者: cochlea    時(shí)間: 2025-3-25 09:16

作者: Indebted    時(shí)間: 2025-3-25 15:24

作者: 尊敬    時(shí)間: 2025-3-25 17:43
Book 2007cal trails to date, including immunotherapy, hyperthermic treatment of colo-rectal and ovarian cancers. Authors also examine regional approaches to therapy, systemic therapy, and the use of carboplatin and paclitaxel as the standard treatment for women with stages III and IV ovarian cancer. Other ch
作者: TRACE    時(shí)間: 2025-3-25 20:01
Management of Ovarian Cancer: The Theory,These investigative efforts suggested the type of antineoplastic agents that should be explored, the patient populations more likely to benefit, and the limitations and potential toxicities of this novel strategy.
作者: 治愈    時(shí)間: 2025-3-26 00:17
Management of Ovarian Cancer: Clinical Trials, residual advanced ovarian cancer ...The three major randomized clinical trials on ovarian cancer are detailed in this chapter. The methodology and outcomes, as well as a critique of their design, are presented. Outcomes of these trials to date are described.
作者: opprobrious    時(shí)間: 2025-3-26 06:22

作者: Melatonin    時(shí)間: 2025-3-26 09:13
Book 2007erapy, systemic therapy, and the use of carboplatin and paclitaxel as the standard treatment for women with stages III and IV ovarian cancer. Other chapters also investigate techniques and procedures in treatment, as well as the future direction of both normothermic and hyperthermic intraperitoneal chemotherapy..
作者: 增長    時(shí)間: 2025-3-26 13:17

作者: extrovert    時(shí)間: 2025-3-26 19:15
Maurie Markman MDseems to serve some useful purpose. This horizontally integrated text on the electronic properties of metals, alloys, semiconductors, insulators, ceramics, and poly- meric materials has been adopted by many universities in the United States as well as abroad, probably because of the relative ease wi
作者: Statins    時(shí)間: 2025-3-26 21:55

作者: biopsy    時(shí)間: 2025-3-27 02:05
Kenneth Jaaback MB BCh, FRANZCOGf the most active areas in modern semiconductor physics. These included resonant tunnelling and superlattice phenomena and the topics of ballistic transport, quantised conductance and anomalous magnetoresistance effects in laterally gated two-dimensional electron systems. Although the main emphasis
作者: 絆住    時(shí)間: 2025-3-27 07:51

作者: trigger    時(shí)間: 2025-3-27 12:34

作者: Dri727    時(shí)間: 2025-3-27 14:31

作者: antipsychotic    時(shí)間: 2025-3-27 21:17

作者: certitude    時(shí)間: 2025-3-27 22:03

作者: Needlework    時(shí)間: 2025-3-28 03:57

作者: 為敵    時(shí)間: 2025-3-28 09:32
C. William Helm MA, MB BChir, FRCSent debate /l/. This is due to the fact that the doping process leads to drastic changes of the relatively well-known structure of pristine (CH). accompanied by a loss of long-range coherence and crystallinity. This limits the application of standard X-ray and neutron diffraction techniques. It has
作者: Graphite    時(shí)間: 2025-3-28 11:17
Jesus Esquivel MD, FACS,Paul H. Sugarbaker MD, FACS, FRCS,C. William Helm MA, MB BChir, FRCSl field in polymer research. It is concerned with the study of the electronic structure of polymers and with physical and chemical properties directly re- lated to this structure. In particular, tutorial and research contributions on electrical, electrochemical, optical, magnetic, lattice dynamical
作者: 山崩    時(shí)間: 2025-3-28 17:17

作者: Heart-Rate    時(shí)間: 2025-3-28 19:38

作者: 臆斷    時(shí)間: 2025-3-29 00:39

作者: 保留    時(shí)間: 2025-3-29 03:43
Management of Ovarian Cancer: Clinical Trials,y. What began as a hypothesis, based on a theoretical mathematical model, has been translated into a 67-mo median survival for women with small-volume residual advanced ovarian cancer ...The three major randomized clinical trials on ovarian cancer are detailed in this chapter. The methodology and ou
作者: pancreas    時(shí)間: 2025-3-29 09:05

作者: 信任    時(shí)間: 2025-3-29 15:05
Immunobiology and Intraperitoneal Immunobiologics in Ovarian Cancer,t of ovarian cancer, as well as other malignancies. Extensive studies have provided support for antigen-driven T-cell activation in vivo. The number of known tumor antigen epitopes is expanding, although advances in this area remain behind that of melanoma. Evidence suggests that the tumor environme




歡迎光臨 派博傳思國際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
五常市| 登封市| 夏河县| 宜兰县| 长兴县| 安平县| 方城县| 芦溪县| 阳原县| 钦州市| 三台县| 毕节市| 连云港市| 柘荣县| 开化县| 观塘区| 宜黄县| 宣武区| 清流县| 麻江县| 巢湖市| 贡觉县| 海兴县| 镇平县| 民乐县| 金湖县| 惠州市| 织金县| 雷波县| 秀山| 玛纳斯县| 平阴县| 永善县| 深泽县| 辽中县| 依兰县| 浮梁县| 梅州市| 合江县| 成都市| 内黄县|